Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Granted Japanese Patent for RIZAPORT® VersaFilm™

SAINT LAURENT, Quebec, Feb. 11, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has received a Decision...
February 07, 2019 16:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Strengthens Senior Management Team

SAINT-LAURENT, Québec, Feb. 07, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT), today announced that it has strengthened its management team with the...
January 30, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA

SAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the U.S. Food and Drug...
January 23, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Provides Update on Phase 2a Montelukast VersaFilm™ Clinical Trial

Eight Alzheimer’s Disease Patients Randomized to Date with Two Additional Sites Expected SAINT LAURENT, Quebec, Jan. 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT)...
January 14, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Provides Update on Cannabis-Infused VersaFilm™ Program Following Recently Proposed Amendments to the Cannabis Act

Working with partner Tilray®, IntelGenx aims to launch oral film products in late-2019 SAINT LAURENT, Quebec, Jan. 14, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT)...
December 26, 2018 16:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Grants Restricted Share Units

SAINT LAURENT, Quebec, Dec. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of directors...
December 12, 2018 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Partners with Gensco® Pharma to Market RIZAPORT® in the United States

SAINT LAURENT, Quebec, Dec. 12, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive...
December 05, 2018 16:54 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Amendment of Stock Option Plan

SAINT LAURENT, Quebec, Dec. 05, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) reported today, that the Company's Board of Directors...
November 30, 2018 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Engages Focus Communications for Investor Relations Program

SAINT LAURENT, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce the engagement of Focus Communications...
November 27, 2018 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Begins Montelukast VersaFilm™ Dosing in Patients with Mild to Moderate Alzheimer’s Disease in Phase 2a Study

SAINT LAURENT, Quebec, Nov. 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that patient dosing has commenced in the Phase 2a...